The difficulty in obtaining standardized sputum samples is one of the drawbacks of the current investigation, and all others investigating sputum as a source of biomarkers in asthma, as it may affect the clinical utility of sputum periostin measurements. The gene discussed is POSTN; the disease is asthma.